13,280
Total Claims
$1.1M
Drug Cost
1,189
Beneficiaries
$920
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-40%
Cost per patient vs peers
$920 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 11,689 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 336 | $262K |
| Rivaroxaban | 182 | $158K |
| Sacubitril/Valsartan | 128 | $98K |
| Dapagliflozin Propanediol | 100 | $81K |
| Ticagrelor | 111 | $78K |
| Empagliflozin | 44 | $45K |
| Evolocumab | 57 | $32K |
| Candesartan Cilexetil | 221 | $26K |
| Sitagliptin Phosphate | 25 | $20K |
| Levothyroxine Sodium | 226 | $20K |
| Metoprolol Succinate | 957 | $17K |
| Omega-3 Acid Ethyl Esters | 281 | $15K |
| Losartan Potassium | 790 | $13K |
| Irbesartan | 443 | $13K |
| Sitagliptin Phos/Metformin Hcl | 15 | $12K |
Prescribing Profile
78
Unique Drugs
$664K
Patient Profile
73
Avg Age
59%
Female
2.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data